相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
A. Michalopoulos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Fosfomycin: an old, new friend?
M. Popovic et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria
Antonia C. Kastoris et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2010)
Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections
Alexandro Rodriguez-Rojas et al.
PLOS ONE (2010)
Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
George L. Daikos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Role of Old Antibiotics in Multidrug Resistant Bacterial Infections
R. Maviglia et al.
CURRENT DRUG TARGETS (2009)
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
Nikos Roussos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
David L. MacLeod et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Patrice Nordmann et al.
LANCET INFECTIOUS DISEASES (2009)
Fosfomycin: Use beyond urinary tract and gastrointestinal infections
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2008)
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: Need for international harmonization in terminology
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2008)
Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobactetiaceae
K. F. Anderson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Carbapenemases:: the versatile β-lactamases
Anne Marie Queenan et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp.
K Lee et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Biological costs and mechanisms of fosfomycin resistance in Escherichia coli
AI Nilsson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Evaluation of antibiotic synergy against Acinetobacter baumannii:: a comparison with Etest, time-kill, and checkerboard methods
CR Bonapace et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2000)
分享论文
